News | Pharmaceuticals
Published on: 14. October 2025

Boehringer Ingelheim: Pharmaceutical giant will also produce in Shanghai in the future

Boehringer Ingelheim has been active in China for 30 years. The German company will now produce one of its best-selling products, the diabetes drug Trajenta, in Shanghai.

Redaktion Table

Sign up now and continue reading immediately

No credit card details required. No automatic renewal.

Sie haben bereits das Table.Briefing Abonnement?

Anmelden und weiterlesen

Last updated: 14. October 2025

Pharmaceuticals Shanghai
Share
Copied!